Promising Therapeutic Effects of High-frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) in Addressing Autism Spectrum Disorder Induced by Valproic Acid

Overview

Journal Front Neurosci

Date 2024 Sep 6

PMID 39238929

Authors

Masoud Afshari

Shahriar Gharibzadeh

Hamidreza Pouretemad

Mehrdad Roghani

Affiliations

Soon will be listed here.

Abstract

Introduction: Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects various regions of the brain. Repetitive transcranial magnetic stimulation (rTMS) is a safe and non-invasive method utilized for stimulating different brain areas. Our objective is to alleviate ASD symptoms using high-frequency rTMS (HF-rTMS) in a rat model of ASD induced by valproic acid (VPA).

Methods: In this investigation, we applied HF-rTMS for ASD treatment, focusing on the hippocampus. Behavioral assessments encompassed core ASD behaviors, as well as memory and recognition tests, alongside evaluations of anxiety and stress coping strategies. Additionally, we analyzed oxidative stress and a related inflammation marker, as well as other biochemical components. We assessed brain-derived neurotrophic factor (BDNF), Microtubule-associated protein-2 (MAP-2), and synaptophysin (SYN). Finally, we examined dendritic spine density in the CA1 area of the hippocampus.

Results: The results demonstrated that HF-rTMS successfully mitigated ASD symptoms, reducing oxidative stress and improving various biochemical factors, along with an increase in dendritic spine density.

Discussion: Collectively, our data suggests that HF-rTMS may effectively alleviate ASD symptoms. These findings could be valuable in clinical research and contribute to a better understanding of the mechanisms underlying ASD.

References

Medina-Fernandez F, Escribano B, Padilla-Del-Campo C, Drucker-Colin R, Pascual-Leone A, Tunez I . Transcranial magnetic stimulation as an antioxidant. Free Radic Res. 2018; 52(4):381-389. DOI: 10.1080/10715762.2018.1434313. View

Kim S, Lee G, Kim S, Kwon Y, Seo E, Lee H . Protective Effects of Repetitive Transcranial Magnetic Stimulation Against Streptozotocin-Induced Alzheimer's Disease. Mol Neurobiol. 2023; 61(3):1687-1703. PMC: 10896897. DOI: 10.1007/s12035-023-03573-8. View

Yang Y, Wang H, Xue Q, Huang Z, Wang Y . High-Frequency Repetitive Transcranial Magnetic Stimulation Applied to the Parietal Cortex for Low-Functioning Children With Autism Spectrum Disorder: A Case Series. Front Psychiatry. 2019; 10:293. PMC: 6520602. DOI: 10.3389/fpsyt.2019.00293. View

Langdon K, Granter-Button S, Harley C, Moody-Corbett F, Peeling J, Corbett D . Cognitive rehabilitation reduces cognitive impairment and normalizes hippocampal CA1 architecture in a rat model of vascular dementia. J Cereb Blood Flow Metab. 2013; 33(6):872-9. PMC: 3677105. DOI: 10.1038/jcbfm.2013.21. View

Alizadeh Makvandi A, Khalili M, Roghani M, Amiri Moghaddam S . Hesperetin ameliorates electroconvulsive therapy-induced memory impairment through regulation of hippocampal BDNF and oxidative stress in a rat model of depression. J Chem Neuroanat. 2021; 117:102001. DOI: 10.1016/j.jchemneu.2021.102001. View

Schartz N, Herr S, Madsen L, Butts S, Torres C, Mendez L . Spatiotemporal profile of Map2 and microglial changes in the hippocampal CA1 region following pilocarpine-induced status epilepticus. Sci Rep. 2016; 6:24988. PMC: 4855223. DOI: 10.1038/srep24988. View

Zuliani G, Trentini A, Brombo G, Rosta V, Guasti P, Romagnoli T . Serum beta-secretase 1 (BACE1) activity increases in patients with mild cognitive impairment. J Neurochem. 2021; 159(3):629-637. DOI: 10.1111/jnc.15513. View

Lima-Castaneda L, Bringas M, Aguilar-Hernandez L, Garces-Ramirez L, Morales-Medina J, Flores G . The antipsychotic olanzapine reduces memory deficits and neuronal abnormalities in a male rat model of Autism. J Chem Neuroanat. 2023; 132:102317. DOI: 10.1016/j.jchemneu.2023.102317. View

Cristiano C, Volpicelli F, Crispino M, Lacivita E, Russo R, Leopoldo M . Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism. Pharmaceuticals (Basel). 2022; 15(2). PMC: 8875614. DOI: 10.3390/ph15020161. View

10.

Marder K, Barbour T, Ferber S, Idowu O, Itzkoff A . Psychiatric Applications of Repetitive Transcranial Magnetic Stimulation. Focus (Am Psychiatr Publ). 2022; 20(1):8-18. PMC: 9063593. DOI: 10.1176/appi.focus.20210021. View

11.

Zhang Z, Ding C, Fu R, Wang J, Zhao J, Zhu H . Low-frequency rTMS modulated the excitability and high-frequency firing in hippocampal neurons of the Alzheimer's disease mouse model. Brain Res. 2024; 1831:148822. DOI: 10.1016/j.brainres.2024.148822. View

12.

Nazari-Serenjeh M, Baluchnejadmojarad T, Hatami-Morassa M, Fahanik-Babaei J, Mehrabi S, Tashakori-Miyanroudi M . Kolaviron neuroprotective effect against okadaic acid-provoked cognitive impairment. Heliyon. 2024; 10(3):e25564. PMC: 10864987. DOI: 10.1016/j.heliyon.2024.e25564. View

13.

Nicolini C, Fahnestock M . The valproic acid-induced rodent model of autism. Exp Neurol. 2017; 299(Pt A):217-227. DOI: 10.1016/j.expneurol.2017.04.017. View

14.

Sakamuru S, Attene-Ramos M, Xia M . Mitochondrial Membrane Potential Assay. Methods Mol Biol. 2016; 1473:17-22. PMC: 5375165. DOI: 10.1007/978-1-4939-6346-1_2. View

15.

Singh Anand K, Dhikav V . Hippocampus in health and disease: An overview. Ann Indian Acad Neurol. 2013; 15(4):239-46. PMC: 3548359. DOI: 10.4103/0972-2327.104323. View

16.

Qin T, Guo L, Wang X, Zhou G, Liu L, Zhang Z . Repetitive transcranial magnetic stimulation ameliorates cognitive deficits in mice with radiation-induced brain injury by attenuating microglial pyroptosis and promoting neurogenesis via BDNF pathway. Cell Commun Signal. 2024; 22(1):216. PMC: 10988892. DOI: 10.1186/s12964-024-01591-0. View

17.

Lenaz G . The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life. 2002; 52(3-5):159-64. DOI: 10.1080/15216540152845957. View

18.

Liao X, Yang J, Wang H, Li Y . Microglia mediated neuroinflammation in autism spectrum disorder. J Psychiatr Res. 2020; 130:167-176. DOI: 10.1016/j.jpsychires.2020.07.013. View

19.

Kim H, Lim C, Kaang B . Neuronal mechanisms and circuits underlying repetitive behaviors in mouse models of autism spectrum disorder. Behav Brain Funct. 2016; 12(1):3. PMC: 4719705. DOI: 10.1186/s12993-016-0087-y. View

20.

Saadat M, Taherian A, Aldaghi M, Raise-Abdullahi P, Sameni H, Vafaei A . Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid. Brain Behav. 2023; 13(11):e3224. PMC: 10636422. DOI: 10.1002/brb3.3224. View